Symposium 1: Pro/Con Therapeutic Drug Monitoring of Monoclonal AntiBody in Oncology

Monday September 14, 1200-1300 (UTC)

Joseph Ciccolini, Aix Marseille Université U105, Institut Paoli Calmettes & APHM
D.J.A.R Moes, Leiden University Medical Center, The Netherlands
Etienne Chatelut, Institut Universitaire du Cancer-Toulouse, France
Jeroen J.M.A. Hendrikx, The Netherlands Cancer Institute – Amsterdam, The Netherlands

Learning Objectives: At the end of this session participants will be able to:
- Describe the current challenges and pitfalls of TDM in Oncology.
- Discuss pharmacokinetic-pharmacodynamic relationships of Mab in Onco-Hematology.
- Formulate their own opinion on this pending issue (i.e., TDM of Mab in Oncology).

Question Title

1. This session overall

	Disagree	Neutral	Agree	Strongly Agree
Sufficient time was allowed for audience participation/active learning	Sufficient time was allowed for audience participation/active learning Disagree	Sufficient time was allowed for audience participation/active learning Neutral	Sufficient time was allowed for audience participation/active learning Agree	Sufficient time was allowed for audience participation/active learning Strongly Agree
The session was free from commercial bias	The session was free from commercial bias Disagree	The session was free from commercial bias Neutral	The session was free from commercial bias Agree	The session was free from commercial bias Strongly Agree

Comments:

Question Title

2. Overall, I would rate this symposium as:

Fair

Good

Excellent

Comments

Question Title

3. Speaker: Joseph Ciccolini

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

4. Speaker: D.J.A.R Moes

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

5. Speaker: Etienne Chatelut

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

6. Speaker: Jeroen J.M.A. Hendrikx

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

7. As a result of attending this session, I am planning to:

a) Discuss the session with my colleagues.

b) Pursue additional learning activities.

c) Create/revise protocols, policies, and/or procedures.

d) Not change my practice.

Symposium 1: Pro/Con Therapeutic Drug Monitoring of Monoclonal AntiBody in Oncology

Monday September 14, 1200-1300 (UTC)

Question Title

1. This session overall

Question Title

2. Overall, I would rate this symposium as:

Question Title

3. Speaker: Joseph Ciccolini

Question Title

4. Speaker: D.J.A.R Moes

Question Title

5. Speaker: Etienne Chatelut

Question Title

6. Speaker: Jeroen J.M.A. Hendrikx

Question Title

7. As a result of attending this session, I am planning to:

Question Title

8. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

9. What topics would you like to be addressed at future conferences to keep you up to date in your profession?

Question Title

* 1. This session overall

Question Title

* 2. Overall, I would rate this symposium as:

Question Title

* 3. Speaker: Joseph Ciccolini

Question Title

* 4. Speaker: D.J.A.R Moes

Question Title

* 5. Speaker: Etienne Chatelut

Question Title

* 6. Speaker: Jeroen J.M.A. Hendrikx

Question Title

* 7. As a result of attending this session, I am planning to:

Question Title

* 8. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

* 9. What topics would you like to be addressed at future conferences to keep you up to date in your profession?

1. This session overall

2. Overall, I would rate this symposium as:

3. Speaker: Joseph Ciccolini

4. Speaker: D.J.A.R Moes

5. Speaker: Etienne Chatelut

6. Speaker: Jeroen J.M.A. Hendrikx

7. As a result of attending this session, I am planning to:

8. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

9. What topics would you like to be addressed at future conferences to keep you up to date in your profession?